Hamilton LaneHLNE
HLNE
About: Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.
Employees: 700
0
Funds holding %
of 7,407 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
103% more first-time investments, than exits
New positions opened: 75 | Existing positions closed: 37
10% more funds holding
Funds holding: 317 [Q3] → 350 (+33) [Q4]
1.3% more ownership
Funds ownership: 95.26% [Q3] → 96.56% (+1.3%) [Q4]
8% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 114
8% less capital invested
Capital invested by funds: $6.5B [Q3] → $5.97B (-$532M) [Q4]
10% less call options, than puts
Call options by funds: $1.8M | Put options by funds: $2.01M
50% less funds holding in top 10
Funds holding in top 10: 4 [Q3] → 2 (-2) [Q4]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$147
7%
upside
Avg. target
$157
14%
upside
High target
$168
22%
upside
3 analyst ratings
0 positive
0%
3 neutral
100%
0 negative
0%
Morgan Stanley Michael Cyprys 46% 1-year accuracy 11 / 24 met price target | 14%upside $157 | Equal-Weight Maintained | 14 Apr 2025 |
Wells Fargo Michael Brown 40% 1-year accuracy 30 / 75 met price target | 7%upside $147 | Equal-Weight Maintained | 8 Apr 2025 |
Keefe, Bruyette & Woods Kyle Voigt 59% 1-year accuracy 17 / 29 met price target | 22%upside $168 | Market Perform Maintained | 5 Feb 2025 |
Financial journalist opinion
Based on 3 articles about HLNE published over the past 30 days
Neutral
PRNewsWire
2 days ago
PAX Health Acquires Richardson Psychiatric Associates, Expanding Mental Health Services for Adults, Adolescents, and Families
RED BANK, N.J. , April 17, 2025 /PRNewswire/ -- PAX Health, a leading behavioral healthcare company backed by HCAP Partners and funds managed by Hamilton Lane (Nasdaq:HLNE), today announced its acquisition of Richardson Psychiatric Associates, a comprehensive outpatient psychiatric practice serving adults, adolescents, children, and families.
Positive
Zacks Investment Research
1 week ago
Hamilton Lane (HLNE) Surges 16.1%: Is This an Indication of Further Gains?
Hamilton Lane (HLNE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Neutral
PRNewsWire
3 weeks ago
Hamilton Lane Partners with Dalan Real Estate to Acquire $74 million NYC Multifamily Portfolio
CONSHOHOCKEN, Pa. , March 25, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, announced an investment in a portfolio of four multifamily assets in lower Manhattan.
Neutral
PRNewsWire
1 month ago
Hamilton Lane Pioneers Access to Private Markets with the First U.S. Infrastructure Evergreen Fund Available to Retail Investors on Republic with a Minimum Initial Investment of $500
Hamilton Lane Private Infrastructure Fund ("HLPIF") allows retail investors access to infrastructure assets previously accessible only to Hamilton Lane's institutional clients Intention to offer investors access to HLPIF in a first-of-its-kind tokenized format through Republic's digital platform CONSHOHOCKEN, Pa. and NEW YORK , March 19, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), one of the world's largest private markets investment firms, today announced the launch of HLPIF on the global investment platform Republic*.
Neutral
PRNewsWire
1 month ago
2025 Hamilton Lane Market Overview: Private Markets Reach an Inflection Point, though Long-Term Fundamentals Remain Strong
Research findings note some areas of concern in private markets in the short-term, with positive tailwinds across long-term fundamentals Report also highlights strong runway for growth within evergreen CONSHOHOCKEN, Pa. , March 12, 2025 /PRNewswire/ -- Hamilton Lane (Nasdaq: HLNE), a leading global private markets investment management firm, published its 2025 Market Overview today.
Neutral
PRNewsWire
1 month ago
Hamilton Lane Launches Private Secondary Fund in the U.S., Further Expanding Global Evergreen Platform
Fund leverages firm's 24+ years of experience in the secondary market and extensive scale to capitalize on what the firm believes to be attractive long-term growth trends CONSHOHOCKEN, Pa. , March 3, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (Nasdaq: HLNE) today announced the launch of the Hamilton Lane Private Secondary Fund ("HLPSF" or "the Fund"), a continuously offered evergreen investment vehicle registered under the Investment Company Act of 1940 ("40 Act"), available to U.S. accredited investor clients, including sufficiently qualified high-net-worth investors and their wealth advisors.
Neutral
CNBC Television
1 month ago
Hamilton Lane co-CEO Erik Hirsch on what is gumming up the IPO pipeline right now
Erik Hirsch, Hamilton Lane Co-CEO, joins 'Closing Bell Overtime' to talk why the IPO boom isn't materializing.
Neutral
Business Wire
1 month ago
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recomm.
Neutral
Business Wire
1 month ago
73 Strings Secures $55m Series B Led by Growth Equity at Goldman Sachs Alternatives
NEW YORK--(BUSINESS WIRE)--73 Strings, the financial intelligence platform using AI to revolutionize data extraction, monitoring, and valuation for the $17.6 Trillion AUM Alternative Asset Management space, has successfully closed a $55m Series B. The round was led by Growth Equity at Goldman Sachs Alternatives, with continued investment from Blackstone Innovations Investments and participation from Golub Capital, Hamilton Lane (Nasdaq: HLNE) and Broadhaven Ventures, solidifying 73 Strings' rep.
Neutral
Business Wire
2 months ago
PSG Closes Two Funds Totaling $8 Billion
BOSTON, MA--(BUSINESS WIRE)--PSG, a leading growth equity firm that specializes in partnering with software and technology-enabled services companies to capitalize on transformational growth, today announced that it has closed two new funds, totaling $8 billion in capital commitments. PSG's sixth North American flagship fund, PSG VI, closed with $6 billion in capital commitments, surpassing its $4.7 billion predecessor fund. The fund received commitments from new and existing investors, includi.
Charts implemented using Lightweight Charts™